Compound
Ipamorelin
Everything in the archive that discusses Ipamorelin in substance — with sources and context.
7 matching articles
Research · 5 September 2026 · 12 min read
Growth Hormone Secretagogues: One Approved Drug, Several Research Compounds, and the Difference
Tesamorelin is an FDA-approved medicine with phase 3 trial data. Ipamorelin and sermorelin are not approved for general use and rest on far thinner evidence. What separates a licensed GHRH analogue from an online 'GH peptide'.
Research · 31 August 2026 · 5 min read
Evaluating Mod GRF 1-29 (CJC-1295 Without DAC): Secretagogue Kinetics, Receptor Dynamics, and Experimental Limitations
An editorial review examining the short-acting GHRH analog Mod GRF 1-29 (CJC-1295 no DAC), its physiological mechanism, pulsatile release profiles, and comparative distinction from long-acting formulations.
Recovery · 31 August 2026 · 5 min read
Analyzing High-Profile Polytrauma Recovery: Peptides, Physiology, and the Evidence Gap
An editorial analysis of high-profile orthopedic recovery narratives, examining the biological mechanisms of polytrauma repair, preclinical peptide signaling, and the methodological challenges of multi-modal rehabilitation.
Longevity · 31 August 2026 · 6 min read
Beyond the Celebrity Spotlight: A Scientific Evaluation of Peptide Signaling and Dermal Remodeling
A critical, evidence-first assessment of injectable, topical, and oral peptide modalities popularized in mainstream anti-aging discussions, evaluating their pharmacokinetic realities and cellular mechanisms.
Longevity · 31 August 2026 · 6 min read
Selectivity in Growth Hormone Secretagogues: A Desk Review of Ipamorelin
An editorial examination of ipamorelin’s receptor selectivity, its historical development, and the current state of preclinical research regarding growth hormone axis modulation.
Research · 31 August 2026 · 4 min read
Evaluating Ipamorelin: Selectivity, Endocrine Dynamics, and Preclinical Evidence
An editorial analysis of ipamorelin, examining its ghrelin-receptor selectivity, pulsatile growth hormone secretagogue profile, preclinical data on bone and gut motility, and key analytical considerations for research environments.
Research · 31 August 2026 · 5 min read
Mechanistic Precision and Metabolic Trade-Offs: A Desk Review of Tesamorelin
An analytical evaluation of Tesamorelin, examining its structural stability as a GHRH analogue, visceral adiposity trial data, glycemic impact, and neurodegenerative research frontiers.